Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.

about

Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.

Item

http://www.wikidata.org/entity/Q47222455

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Outcomes after second surgery ...... rospective case-control study.

@en

Outcomes after second surgery ...... rospective case-control study.

@nl

type

Item

label

Outcomes after second surgery ...... rospective case-control study.

@en

Outcomes after second surgery ...... rospective case-control study.

@nl

prefLabel

Outcomes after second surgery ...... rospective case-control study.

@en

Outcomes after second surgery ...... rospective case-control study.

@nl

P1476

Outcomes after second surgery ...... trospective case-control study

@en

P2093

Elizabeth H Barnes

http://www.w3.org/2001/XMLSchema#string

Hui Gan

http://www.w3.org/2001/XMLSchema#string

Katharine J Drummond

http://www.w3.org/2001/XMLSchema#string

Mustafa Khasraw

http://www.w3.org/2001/XMLSchema#string

Patrick A Tully

http://www.w3.org/2001/XMLSchema#string

Zarnie Lwin

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Scale to predict survival after surgery for recurrent glioblastoma multiforme

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method

Has the survival of patients with glioblastoma changed over the years?

Multiple resections for patients with glioblastoma: prolonging survival.

P2888

s11060-017-2731-2

P304

409-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2731-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Rosalind Jeffree

Alysson Wann

P577

2018-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29294233

http://www.w3.org/2001/XMLSchema#string